Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy

    Policy - Page 4

    Sick, loss-making Hindustan Antibiotics up for sale: Minister

    Sick, loss-making Hindustan Antibiotics up for sale: Minister

    Medical Dialogues Bureau24 Dec 2019 6:00 PM IST
    New Delhi: Loss making Hindustan Antibiotics Limited (HAL) is going to be sold off based on the recommendations of a Committee of Ministers.The...
    After Cipla, Glenmark Digihaler secures NPPA nod for separate price; Details

    After Cipla, Glenmark Digihaler secures NPPA nod for separate price; Details

    Farhat Nasim23 Dec 2019 4:28 PM IST
    New Delhi: The National Pharmaceuticals Pricing Authority (NPPA) recently approved the price for the digital dose counter brand ’Digihaler’...
    NPPA fixes price of Cipla Synchrobreathe inhaler device; Details

    NPPA fixes price of Cipla Synchrobreathe inhaler device; Details

    Medical Dialogues Bureau22 Dec 2019 2:26 PM IST
    New Delhi: Price of Synchrobreathe inhaler device manufactured by pharma giant Cipla has been set at Rs 67.20 after the National Pharmaceutical...
    Medical Devices Draft Bill 2019: Niti Ayog holds meeting with affected patients, stakeholders

    Medical Devices Draft Bill 2019: Niti Ayog holds meeting with affected patients, stakeholders

    Farhat Nasim21 Dec 2019 2:52 PM IST
    New Delhi: The Government's think tank- Niti Ayog has stepped up in curing the malaise due to faulty medical devices as it has gone ahead and met the...
    Indian Pharmacopoeia recognized by Afghanistan

    Indian Pharmacopoeia recognized by Afghanistan

    Medical Dialogues Bureau21 Dec 2019 9:00 AM IST
    With this, a new beginning has been made and Afghanistan has become the first country to recognize Indian Pharmacopoeia (IP) pursuant to the efforts...
    NPPA fixes retail price of 44 combo drugs including Metformin, Vildagliptin, Paracetamol; Details

    NPPA fixes retail price of 44 combo drugs including Metformin, Vildagliptin, Paracetamol; Details

    Farhat Nasim20 Dec 2019 11:55 AM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    NPPA show-cause notices to Sun Pharma, Glenmark, Abbott, Lupin for self-exemption from price cap for anti-diabetic drugs

    NPPA show-cause notices to Sun Pharma, Glenmark, Abbott, Lupin for self-exemption from price cap for anti-diabetic drugs

    Farhat Nasim19 Dec 2019 2:26 PM IST
    New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has called for action and issued show-cause notices to drug giants including Sun...
    Withdraw decision of NPPA increasing ceiling price of essential life-saving drug; CPI writes to PM

    Withdraw decision of NPPA increasing ceiling price of essential life-saving drug; CPI writes to PM

    Medical Dialogues Bureau19 Dec 2019 1:13 PM IST
    In the letter addressed to Prime Minister Modi, Viswam said, "On behalf of the common people in India, I request you to take immediate steps to...
    Medical Device Park: DoP to provide financial assistance to tune of Rs 25 crore; says MOS Health

    Medical Device Park: DoP to provide financial assistance to tune of Rs 25 crore; says MOS Health

    Farhat Nasim17 Dec 2019 2:47 PM IST
    Choubey further mentioned that DoP has received four proposals under this sub-scheme from Andhra Pradesh Medtech Zone Ltd. (AMTZ), Andhra Pradesh;...
    Issue of Corruption in CDSCO raised in Parliament; Details

    Issue of Corruption in CDSCO raised in Parliament; Details

    Farhat Nasim16 Dec 2019 12:56 PM IST
    New Delhi: The sensitive issue of corruption plaguing every sector including the nodal drug regulatory body, Central Drugs Control Organisation...
    CDSCO to set up Public Relations Offices at all Zonal, Sub-Zonal Offices for regulator guidance

    CDSCO to set up Public Relations Offices at all Zonal, Sub-Zonal Offices for regulator guidance

    Farhat Nasim15 Dec 2019 1:42 PM IST
    New Delhi: In order to make regulatory guidance more accessible across the country, the nodal drug regulator, Central Drugs Standard Control...
    Regular review of CDSCO functioning, deaths due to spurious drugs: Minister

    Regular review of CDSCO functioning, deaths due to spurious drugs: Minister

    Medical Dialogues Bureau15 Dec 2019 9:15 AM IST
    New Delhi: Through a recent reply, the Union Health Minister, Dr Harsh Vardhan informed the Parliament about the regular review of the function of the...
    PrevNext

    Popular Stories

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US

    Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    Transasia-Erba group unveils TB testing device MX 16

    Transasia-Erba group unveils TB testing device MX 16

    Sun Pharma reports Rs 6923.40 crore total expenses in Q3

    Sun Pharma reports Rs 6923.40 crore total expenses in Q3

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok